Lang R, Maxrath A, Laaser U, Meurer K A, Kaufmann W
Klin Wochenschr. 1978 Nov 15;56(22):1097-108. doi: 10.1007/BF01477131.
In 22 patients with essential hypertension plasma levels and urine excretions of sodium and noradrenaline were studied before, during and after long-term beta-blockade with pindolol. The relation between mean blood pressure and the quotient of sodium-/noradrenaline-excretion changed during treatment (placebo r=-0.34; pindolol r=+0.31). During placebo there existed a significant (p is less than 0.03) correlation between blood pressure and sodium-excretion which disappeared during beta-blockade. No correlation between blood pressure and noradrenaline was seen during placebo, whereas during beta-blockade a significant (p is less than 0.003) correlation was observed. In contrast to the placebo period there was a significant positive correlation between sodium- and noradrenaline-excretion during long-term treatment with pindolol. It is concluded that whole-body balance of sodium and noradrenaline is an important factor in essential hypertension.
对22例原发性高血压患者,在使用吲哚洛尔进行长期β受体阻滞剂治疗前、治疗期间及治疗后,研究了其血浆中钠和去甲肾上腺素的水平以及尿排泄量。治疗期间,平均血压与钠排泄/去甲肾上腺素排泄比值之间的关系发生了变化(安慰剂组r = -0.34;吲哚洛尔组r = +0.31)。在安慰剂治疗期间,血压与钠排泄之间存在显著相关性(p < 0.03),而在β受体阻滞剂治疗期间这种相关性消失。在安慰剂治疗期间未观察到血压与去甲肾上腺素之间的相关性,而在β受体阻滞剂治疗期间观察到显著相关性(p < 0.003)。与安慰剂治疗期相比,在使用吲哚洛尔进行长期治疗期间,钠排泄与去甲肾上腺素排泄之间存在显著正相关。得出的结论是,钠和去甲肾上腺素的全身平衡是原发性高血压的一个重要因素。